H.B. 435 Undiagnosed Children Insurance Coverage Amendments

Bill Sponsor:

Rep. Eliason, Steve
Floor Sponsor:

Sen. Buxton, David G.
  • Drafting Attorney: Daniel M. Cheung
  • Fiscal Analyst: Russell T. Frandsen
  • Information
    • Last Action: 26 Mar 2019, Governor Signed
    • Last Location: Lieutenant Governor's office for filing
    • Effective Date: 14 May 2019
    • Session Law Chapter: 320

H.B. 435

1     
UNDIAGNOSED CHILDREN INSURANCE COVERAGE

2     
AMENDMENTS

3     
2019 GENERAL SESSION

4     
STATE OF UTAH

5     
Chief Sponsor: Steve Eliason

6     
Senate Sponsor: David G. Buxton

7     

8     LONG TITLE
9     General Description:
10          This bill requires the state Medicaid program and Public Employees' Benefit and
11     Insurance Program to cover exome sequence testing.
12     Highlighted Provisions:
13          This bill:
14          ▸     defines terms; and
15          ▸     requires the state Medicaid program and Public Employees' Benefit and Insurance
16     Program to cover exome sequence testing for certain enrollees.
17     Money Appropriated in this Bill:
18          None
19     Other Special Clauses:
20          None
21     Utah Code Sections Affected:
22     ENACTS:
23          26-18-25, Utah Code Annotated 1953
24          49-20-419, Utah Code Annotated 1953
25     

26     Be it enacted by the Legislature of the state of Utah:
27          Section 1. Section 26-18-25 is enacted to read:
28          26-18-25. Coverage of exome sequence testing.
29          (1) As used in this section, "exome sequence testing" means a genomic technique for
30     sequencing the genome of an individual for diagnostic purposes.
31          (2) The Medicaid program shall reimburse for exome sequence testing:
32          (a) for an enrollee who:
33          (i) is younger than 21 years of age; and
34          (ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related
35     tests;
36          (b) performed by a nationally recognized provider with significant experience in exome
37     sequence testing;
38          (c) that is medically necessary; and
39          (d) at a rate set by the Medicaid program.
40          Section 2. Section 49-20-419 is enacted to read:
41          49-20-419. Coverage of exome sequence testing.
42          (1) As used in this section, "exome sequence testing" means a genomic technique for
43     sequencing the genome of an individual for diagnostic purposes.
44          (2) Beginning July 1, 2019, the program shall provide coverage for exome sequence
45     testing:
46          (a) for a covered individual within the state risk pool who:
47          (i) is younger than 21 years of age; and
48          (ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related
49     tests;
50          (b) performed by a nationally recognized provider with significant experience in exome
51     sequence testing;
52          (c) that is medically necessary; and
53          (d) at a rate set by the program.
Bill Status / Votes
• Senate Actions • House Actions • Fiscal Actions • Other Actions
DateActionLocationVote
2/27/2019 Bill Numbered but not DistributedLegislative Research and General Counsel
2/27/2019 Numbered Bill Publicly DistributedLegislative Research and General Counsel
2/28/2019 House/ received bill from Legislative ResearchClerk of the House
2/28/2019 House/ 1st reading (Introduced)House Rules Committee
3/4/2019 House/ to standing committeeHouse Health and Human Services Committee
3/4/2019 House/ received fiscal note from Fiscal AnalystHouse Health and Human Services Committee
3/4/2019 House Comm - Substitute Recommendation from # 0 to # 1House Health and Human Services Committee10 0 2
3/4/2019 House Comm - Favorable RecommendationHouse Health and Human Services Committee10 0 2
3/5/2019 (10:29:34 AM)House/ comm rpt/ substitutedHouse Health and Human Services Committee
3/5/2019 (10:29:35 AM)House/ 2nd readingHouse 3rd Reading Calendar for House bills
3/5/2019 (7:13:54 PM)House/ 3rd readingHouse 3rd Reading Calendar for House bills
3/5/2019 (7:24:05 PM)House/ passed 3rd readingSenate Secretary72 0 3
3/5/2019 (7:24:07 PM)House/ to SenateSenate Secretary
3/6/2019 Senate/ received from HouseWaiting for Introduction in the Senate
3/6/2019 Senate/ 1st reading (Introduced)Senate Rules Committee
3/6/2019 LFA/ fiscal note sent to sponsorSenate Rules Committee
3/7/2019 Senate/ to standing committeeSenate Health and Human Services Committee
3/8/2019 LFA/ fiscal note publicly availableSenate Health and Human Services Committee
3/8/2019 Senate Comm - Favorable RecommendationSenate Health and Human Services Committee4 0 4
3/11/2019 (4:30:42 PM)Senate/ committee report favorableSenate Health and Human Services Committee
3/11/2019 (4:30:43 PM)Senate/ placed on 2nd Reading CalendarSenate 2nd Reading Calendar
3/13/2019 (2:33:47 PM)Senate/ 2nd & 3rd readings/ suspensionSenate 2nd Reading Calendar
3/13/2019 (2:34:26 PM)Senate/ circledSenate 2nd Reading CalendarVoice vote
3/13/2019 (2:38:47 PM)Senate/ uncircledSenate 2nd Reading CalendarVoice vote
3/13/2019 (2:41:23 PM)Senate/ passed 2nd & 3rd readings/ suspensionSenate President25 0 4
3/13/2019 (2:41:24 PM)Senate/ signed by President/ returned to HouseHouse Speaker
3/13/2019 (2:41:25 PM)Senate/ to HouseHouse Speaker
3/13/2019 House/ received from SenateHouse Speaker
3/13/2019 House/ signed by Speaker/ sent for enrollingLegislative Research and General Counsel / Enrolling
3/15/2019 Bill Received from House for EnrollingLegislative Research and General Counsel / Enrolling
3/15/2019 Draft of Enrolled Bill PreparedLegislative Research and General Counsel / Enrolling
3/21/2019 Enrolled Bill Returned to House or SenateClerk of the House
3/21/2019 House/ enrolled bill to PrintingClerk of the House
3/21/2019 House/ received enrolled bill from PrintingClerk of the House
3/21/2019 House/ to GovernorExecutive Branch - Governor
3/26/2019 Governor SignedLieutenant Governor's office for filing